TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.

On August 14, 2017, Tonix Pharmaceuticals Holding Corp. (the “Company”) announced its operating results for the second fiscal quarter ended June 30, 2017. A copy of the press release that discusses this matter is filed as Exhibit 99.01 to, and incorporated by reference in, this report. The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document to the Securities Act of 1933, except as shall be expressly set forth by specific reference in any such filing.

(d)Exhibits.

* Furnished herewith.

Tonix Pharmaceuticals Holding Corp. Exhibit
EX-99.01 2 s107157_ex99-01.htm EXHIBIT 99.1   Exhibit 99.01         Tonix Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Programs Update   Interim Analysis of Phase 3 HONOR study of Tonmya® (Cyclobenzaprine HCI Sublingual Tablets) in Military-Related PTSD Expected 1H18 and Topline Results Expected 2H18   NEW YORK,…
To view the full exhibit click here